Among all mGlu receptors, abnormal glutamatergic signaling of mGluR5 leads to a series of CNS-related diseases such as depression, schizophrenia, X-brittle syndrome, and Parkinson’s disease [2]. This evidence concerns the gene GRM5 and depressive symptom measurement.